Q4 momentum: orders jump, sales accelerate, and demand broadens
discoverIE Group has finished FY2026 with a clear upshift in tempo. In the fourth quarter to 31 March, Group orders rose 16% at constant exchange rates (CER) and 15% organically, outpacing sales for the third consecutive quarter. That “orders ahead of sales” dynamic typically signals a book-to-bill ratio above 1.0 – in plain English, the pipeline is building.
Q4 sales also moved higher, up 6% at CER and 5% organically, with a 1% contribution from acquisitions. The demand pick-up was broad-based across operating units and end markets, which matters because it suggests the recovery is not reliant on a single customer or niche.
- Magnetics & Controls: strong rebound in demand from major industrial and medical customers; Controls orders grew strongly organically for the third quarter running.
- Sensing & Connectivity: encouraging progress, led by better orders from industrial, security and wireless segments.
Definitions checkpoint: CER strips out currency swings to show underlying trading. “Organic” excludes the first 12 months of acquired businesses to give a like-for-like view.
Full-year FY2026: steady growth, stronger finish, and margin resilience
Across the full year, discoverIE delivered growth and ended on the front foot. Group orders increased 9% at CER (5% organic) and remained ahead of sales, lifting the order book by 6% versus the first half. That should provide some visibility into the new financial year.
Group sales rose 5% both reported and at CER, with 2% organic growth and a 3% contribution from acquisitions. Importantly, organic sales grew 2% in both divisions, and gross margins were described as “robust” – a positive signal for pricing power and product mix, although the exact margin level was not disclosed.
Management highlights continued efficiencies from the international footprint and lower interest costs supporting earnings momentum. The Group is on track to deliver another year of adjusted EPS growth in line with consensus market expectations, which stand at 40.1p. No specific EPS figure was guided, but the “in line” language implies delivery against that benchmark.
Capacity investments to fuel the next leg
To meet the acceleration in demand, discoverIE stepped up investments in capacity and commercial reach. Additional production in Thailand is underway, and a new enlarged facility in India is set to complete in the first half of the new financial year. The Group also expanded engineering and sales capacity in the US and Europe – all aimed at supporting future growth and shortening lead times for customers.
M&A update: Trival completes, balance sheet stays within target range
Regulatory approval for the acquisition of Trival Antene (“Trival”) has been received, and completion occurred earlier this month. Trival is a Slovenia-based designer and manufacturer of communication antennae and masts for defence and industrial markets – a neat fit with discoverIE’s Sensing & Connectivity capabilities and its focus on structural growth niches like security and industrial connectivity.
Funding headroom looks sensible. Year-end gearing is expected at approximately 1.2x (net debt divided by underlying EBITDA). On a pro forma basis including Trival, gearing is expected to be around 1.7x – comfortably within the Group’s target range, leaving scope for further bolt-ons. Management also notes a healthy pipeline of acquisitions alongside organic “design wins”, suggesting the roll-up plus organic growth playbook remains intact.
Why this update matters for investors
The shift in Q4 is the headline. Orders up 16% at CER and ahead of sales for a third straight quarter indicate improving demand and growing visibility. Combined with a 6% increase in the order book since H1, discoverIE enters the new year with a fuller pipeline.
There are three other important signals:
- Margin resilience: Gross margins remain robust (not disclosed numerically), which supports the quality of earnings.
- Operational leverage: Efficiencies and lower interest costs are helping EPS, even as the Group invests in capacity.
- Disciplined growth: Gearing near 1.2x (1.7x including Trival) leaves room for more targeted M&A without over-stretching the balance sheet.
The balanced take: positives, watch-outs, and what’s next
What looks good
- Q4 acceleration: Both orders and sales strengthened, with orders clearly outpacing sales – a constructive set-up for FY2027.
- Broad-based demand: Industrial, medical, security and wireless all contributed. That diversification reduces end-market risk.
- EPS trajectory: “In line with consensus” at 40.1p indicates no nasty surprises and continued progress.
- Capacity and capability: New production in Thailand and a larger Indian facility should support growth and resilience in the supply chain.
- Strategic add-on: Trival complements Sensing & Connectivity and positions discoverIE deeper in defence and industrial communications.
What to keep an eye on
- Organic growth base: Full-year organic sales were up 2% – solid, not spectacular. The Q4 bounce needs to sustain to move the needle.
- Execution risk: Ramping new capacity and integrating Trival require tight execution to protect margins and delivery times.
- Macro and FX: The company reports CER growth to smooth currency noise, but swings in USD, EUR and Nordic currencies still affect reported results and input costs.
- Disclosure gaps: Gross margin levels and detailed divisional profitability were not disclosed here and will matter at prelims (3 June 2026).
discoverIE at a glance: focus, scale, and structure
discoverIE designs and manufactures customised electronic components for OEMs across two divisions – Magnetics & Controls, and Sensing & Connectivity. The model emphasises application-specific components that are then supplied through the life of the customer’s product, driving repeat revenue and long-term relationships.
The Group focuses on structural growth markets – medical, electrification of transportation, renewable energy, security, and industrial automation & connectivity – and aims to grow organically ahead of GDP through the cycle, supplemented by complementary acquisitions. It employs around 4,600 people across 21 countries, with principal operating units in Mainland Europe, the UK, China, Sri Lanka, India and North America.
Key numbers and takeaways
| Metric | Q4 FY2026 | Full Year FY2026 | Notes |
|---|---|---|---|
| Orders growth (CER) | +16% | +9% | Orders ahead of sales for third consecutive quarter |
| Orders growth (organic) | +15% | +5% | Organic excludes first 12 months post-acquisition |
| Sales growth (CER) | +6% | +5% | Reported and CER both +5% for the full year |
| Sales growth (organic) | +5% | +2% | Acquisitions contributed 1% in Q4, 3% full year |
| Divisional organic sales | – | +2% in both divisions | Magnetics & Controls and Sensing & Connectivity |
| Gross margins | – | Robust | Exact figure not disclosed |
| Adjusted EPS outlook | On track, in line with consensus | Consensus market expectations: 40.1p | |
| Gearing (year-end) | c.1.2x | Net debt / underlying EBITDA | |
| Pro forma gearing (incl. Trival) | c.1.7x | Within target range | |
| Results date | 3 June 2026 (prelims) | – | |
Bottom line
This is a constructive update. After a steady first nine months, Q4 showed a clear acceleration with orders running ahead of sales, healthier demand across key end-markets, and continued margin resilience. The balance sheet remains within comfort, Trival is now onboard, and capacity is expanding where needed.
If the Q4 momentum carries into the new financial year, discoverIE looks well set for another period of growth. The prelims in June should fill in the detail on margins, cash conversion and divisional profitability – the next catalysts to watch.
